278 related articles for article (PubMed ID: 36071985)
1. Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges.
Chantre-Justino M; Alves G; Delmonico L
Explor Target Antitumor Ther; 2022; 3(4):533-552. PubMed ID: 36071985
[TBL] [Abstract][Full Text] [Related]
2. Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB; De Carvalho AC; Melendez ME; Lopes Carvalho A
Expert Rev Mol Diagn; 2018 Jan; 18(1):85-112. PubMed ID: 29134827
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of HPV-Positive Head and Neck Squamous Cell Carcinoma with Circulating and Salivary DNA Biomarkers.
Borsetto D; Cheng J; Payne K; Nankivell P; Batis N; Rao K; Bhide S; Li F; Kim Y; Mehanna H; Wong D
Crit Rev Oncog; 2018; 23(3-4):235-245. PubMed ID: 30311577
[TBL] [Abstract][Full Text] [Related]
4. A Review of HPV-Related Head and Neck Cancer.
Kobayashi K; Hisamatsu K; Suzui N; Hara A; Tomita H; Miyazaki T
J Clin Med; 2018 Aug; 7(9):. PubMed ID: 30150513
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
[No Abstract] [Full Text] [Related]
6. Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer.
Kumar P; Gupta S; Das BC
Transl Oncol; 2024 Feb; 40():101827. PubMed ID: 38042138
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and genotypes of human papillomavirus in saliva and tumor samples of head and neck cancer patients in Hungary.
Hettmann A; Demcsák A; Bach Á; Decsi G; Dencs Á; Pálinkó D; Rovó L; Terhes G; Urbán E; Buzás K; Nagy K; Takács M; Minarovits J
Infect Genet Evol; 2018 Apr; 59():99-106. PubMed ID: 29408738
[TBL] [Abstract][Full Text] [Related]
8. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
9. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
10. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
11. Frequency and genotype of human papillomavirus among Sudanese patients with head and neck tumours.
Ahmed HG; Mustafa SA; Eltom FM; Babiker AY
Ecancermedicalscience; 2012; 6():282. PubMed ID: 23226164
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy.
Canning M; Guo G; Yu M; Myint C; Groves MW; Byrd JK; Cui Y
Front Cell Dev Biol; 2019; 7():52. PubMed ID: 31024913
[TBL] [Abstract][Full Text] [Related]
14. Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas.
Chang PH; Wang HM; Kuo YC; Lee LY; Liao CJ; Kuo HC; Hsu CL; Liao CT; Lin SH; Huang PW; Wu TM; Hsieh JC
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834510
[TBL] [Abstract][Full Text] [Related]
15. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.
Shaikh MH; Bortnik V; McMillan NA; Idris A
Microb Pathog; 2019 Jul; 132():162-165. PubMed ID: 31054871
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
Aldalwg MAH; Brestovac B
Head Neck Pathol; 2017 Sep; 11(3):377-384. PubMed ID: 28176136
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
Gubanova E; Brown B; Ivanov SV; Helleday T; Mills GB; Yarbrough WG; Issaeva N
Clin Cancer Res; 2012 Mar; 18(5):1257-67. PubMed ID: 22247495
[TBL] [Abstract][Full Text] [Related]
18. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
[TBL] [Abstract][Full Text] [Related]
19. An updated overview of HPV-associated head and neck carcinomas.
Zaravinos A
Oncotarget; 2014 Jun; 5(12):3956-69. PubMed ID: 24970795
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.
Klussmann JP; Weissenborn SJ; Wieland U; Dries V; Kolligs J; Jungehuelsing M; Eckel HE; Dienes HP; Pfister HJ; Fuchs PG
Cancer; 2001 Dec; 92(11):2875-84. PubMed ID: 11753961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
